Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment

被引:78
作者
Faustino, NA
Cooper, TA
机构
[1] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA
[3] Univ Porto, Grad Program Basic & Appl Biol, ICBAS, Oporto, Portugal
关键词
D O I
10.1128/MCB.25.3.879-887.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ETR-3 (also know as BRUNOL3, NAPOR, and CUGBP2) is one of six members of the CELF (CUG-BP1- and ETR-3-like factor) family of splicing regulators. ETR-3 regulates splicing by direct binding to the pre-mRNA. We performed systematic evolution of ligands by exponential enrichment (SELEX) to identify the preferred binding sequence of ETR-3. After five rounds of SELEX, ETR-3 selected UG-rich sequences. in particular UG repeats and UGUU motifs. Either of these selected motifs was able to restore ETR-3 binding and responsiveness to a nonresponsive splicing reporter in vivo. Moreover, this effect was not specific to ETR-3 since minigenes containing either of the two motifs were responsive to two other CELF proteins (CUG-BP1 and CELF4), indicating that different members of the CELF family can mediate their effects via a common binding site. Using the SELEX-identified motifs to search the human genome. we identified several possible new ETR-3 targets. We created minigenes for two of these genes, the CFTR and MTMR1 genes. and confirmed that ETR-3 regulates their splicing patterns. For the CFTR minigene this regulation was demonstrated to be dependent on the presence of the putative binding site identified in our screen. These results validate this approach to search for new targets for RNA processing proteins.
引用
收藏
页码:879 / 887
页数:9
相关论文
共 50 条
  • [1] Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing - CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor
    Anant, S
    Henderson, JO
    Mukhopadhyay, D
    Navaratnam, N
    Kennedy, S
    Min, J
    Davidson, NO
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) : 47338 - 47351
  • [2] Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway
    Blondeau, F
    Laporte, J
    Bodin, S
    Superti-Furga, G
    Payrastre, B
    Mandel, JL
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (15) : 2223 - 2229
  • [3] Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2
    Bolino, A
    Muglia, M
    Conforti, FL
    LeGuern, E
    Salih, MAM
    Georgiou, DM
    Christodoulou, K
    Hausmanowa-Petrusewicz, I
    Mandich, P
    Schenone, A
    Gambardella, A
    Bono, F
    Quattrone, A
    Devoto, M
    Monaco, AP
    [J]. NATURE GENETICS, 2000, 25 (01) : 17 - 19
  • [4] An analysis of the sequence requirements of EDEN-BP for specific RNA binding
    Bonnet-Corven, S
    Audic, Y
    Omilli, F
    Osborne, HB
    [J]. NUCLEIC ACIDS RESEARCH, 2002, 30 (21) : 4667 - 4674
  • [5] The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo
    Buckanovich, RJ
    Darnell, RB
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (06) : 3194 - 3201
  • [6] Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells
    Buj-Bello, A
    Furling, D
    Tronchère, H
    Laporte, J
    Lerouge, T
    Butler-Browne, GS
    Mandel, JL
    [J]. HUMAN MOLECULAR GENETICS, 2002, 11 (19) : 2297 - 2307
  • [7] Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing
    Charlet-B, N
    Savkur, RS
    Singh, G
    Philips, AV
    Grice, EA
    Cooper, TA
    [J]. MOLECULAR CELL, 2002, 10 (01) : 45 - 53
  • [8] Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing
    Charlet-B, N
    Logan, P
    Singh, G
    Cooper, TA
    [J]. MOLECULAR CELL, 2002, 9 (03) : 649 - 658
  • [9] MUTATIONS IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH CONGENITAL ABSENCE OF THE VAS-DEFERENS
    CHILLON, M
    CASALS, T
    MERCIER, B
    BASSAS, L
    LISSENS, W
    SILBER, S
    ROMEY, MC
    RUIZROMERO, J
    VERLINGUE, C
    CLAUSTRES, M
    NUNES, V
    FEREC, C
    ESTIVILL, X
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (22) : 1475 - 1480
  • [10] Isolation and expression of Napor/CUG-BP2 in embryo development
    Choi, DK
    Yoo, KW
    Hong, SK
    Rhee, M
    Sakaki, Y
    Kim, CH
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 305 (03) : 448 - 454